Barbara Withers
Direttore Tecnico/Scientifico/R&S presso OCUPHIRE PHARMA, INC.
Posizioni attive di Barbara Withers
Società | Posizione | Inizio | Fine |
---|---|---|---|
OCUPHIRE PHARMA, INC. | Direttore Tecnico/Scientifico/R&S | - | - |
Storia della carriera di Barbara Withers
Precedenti posizioni note di Barbara Withers
Società | Posizione | Inizio | Fine |
---|---|---|---|
PFIZER, INC. | Corporate Officer/Principal | - | - |
United BioSource Corp.
United BioSource Corp. Miscellaneous Commercial ServicesCommercial Services United BioSource Corp. is a scientific and medical affairs organization that partners with life science companies to develop and commercialize their products. The company is involved in pre- and post-approval product development; pricing, coverage, reimbursement, and access strategies; and medical publication and communications. United BioSource Corp. was founded by Ethan D. Leder and Mark P. Cleinin in 2003 and is headquartered in Chevy Chase, MD. | Corporate Officer/Principal | - | - |
AERPIO PHARMACEUTICALS | Corporate Officer/Principal | - | - |
Formazione di Barbara Withers
The Wayne State University School of Medicine | Doctorate Degree |
University of Michigan | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 7 |
Posizioni
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Settori
Health Technology | 4 |
Consumer Services | 3 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
OCUPHIRE PHARMA, INC. | Health Technology |
PFIZER, INC. | Health Technology |
Aziende private | 2 |
---|---|
Aerpio Pharmaceuticals, Inc.
Aerpio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerpio Pharmaceuticals Inc. is a biopharmaceutical company, which engages in the research and development of treatments for ocular diseases. The firm's product candidate is AKB-9778, a small molecule activator of the Tie2 pathway, which completed the Phase 2a clinical trial for the treatment of diabetic retinopathy. It also develops ARP-1536, a humanized monoclonal antibody that is in preclinical development stage for the treatment of diabetic vascular complications; and AKB-4924, a selective stabilizer of hypoxia-inducible factor-1 alpha, which has completed a single ascending dose clinical trial for the treatment of inflammatory bowel disease. The company was founded by Joseph H. Garder on November 16, 2007 and is headquartered in Cincinnati, OH. | Health Technology |
United BioSource Corp.
United BioSource Corp. Miscellaneous Commercial ServicesCommercial Services United BioSource Corp. is a scientific and medical affairs organization that partners with life science companies to develop and commercialize their products. The company is involved in pre- and post-approval product development; pricing, coverage, reimbursement, and access strategies; and medical publication and communications. United BioSource Corp. was founded by Ethan D. Leder and Mark P. Cleinin in 2003 and is headquartered in Chevy Chase, MD. | Commercial Services |
- Borsa valori
- Insiders
- Barbara Withers
- Esperienza